Patents by Inventor Birgit Hauer

Birgit Hauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10964459
    Abstract: An electrical resistor has a resistance conductor, which is applied to a carrier layer, and two connection elements, which are electrically conductively connected to the resistance conductor. The two connection elements are configured to each be welded or soldered to an electrical contact in order to electrically contact the resistor. The resistance conductor for each connection element has a region that overlaps the corresponding connection element. The overlap region is in electrical contact with the corresponding connection element.
    Type: Grant
    Filed: January 23, 2019
    Date of Patent: March 30, 2021
    Assignee: Biotronik SE & Co. KG
    Inventors: Marc Hauer, Birgit Neubauer, Jochen Held, Martin Henschel, Thomas Pfefferkorn, Alexander Dettmer
  • Publication number: 20190228887
    Abstract: An electrical resistor has a resistance conductor, which is applied to a carrier layer, and two connection elements, which are electrically conductively connected to the resistance conductor. The two connection elements are configured to each be welded or soldered to an electrical contact in order to electrically contact the resistor. The resistance conductor for each connection element has a region that overlaps the corresponding connection element. The overlap region is in electrical contact with the corresponding connection element.
    Type: Application
    Filed: January 23, 2019
    Publication date: July 25, 2019
    Inventors: MARC HAUER, BIRGIT NEUBAUER, JOCHEN HELD, MARTIN HENSCHEL, THOMAS PFEFFERKORN, ALEXANDER DETTMER
  • Patent number: 7235248
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva]2-Ciclosporin, in “microemulsion pre-concentrate” and microemulsion form. The compositions typically comprise (1.1) a C1-5alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: October 2, 2002
    Date of Patent: June 26, 2007
    Assignee: Novartis AG
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter
  • Patent number: 6844459
    Abstract: Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesterified corn oil is provided representing a mixed mono-, di- and tri-glyceride suitable for the novel formulation. Dosage forms include in particular oral dosage forms.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: January 18, 2005
    Assignee: Novartis AG
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Jacky Vonderscher
  • Publication number: 20030199433
    Abstract: Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesterified corn oil is provided representing a mixed mono-, di- and tri-glyceride suitable for the novel formulation. Dosage forms include in particular oral dosage forms.
    Type: Application
    Filed: May 20, 2003
    Publication date: October 23, 2003
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Jacky Vonderscher
  • Publication number: 20030143250
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva]2-Ciclosporin, in “microemulsion pre-concentrate” and microemulsion form. The compositions typically comprise (1.1) a C1-5alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Application
    Filed: October 2, 2002
    Publication date: July 31, 2003
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter
  • Publication number: 20030104990
    Abstract: Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesterified corn oil is provided representing a mixed mono-, di- and tri-glyceride suitable for the novel formulation. Dosage forms include in particular oral dosage forms.
    Type: Application
    Filed: March 11, 2002
    Publication date: June 5, 2003
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Jacky Vonderscher
  • Publication number: 20010036918
    Abstract: Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesterified corn oil is provided representing a mixed mono-, di- and tri-glyceride suitable for the novel formulation. Dosage forms include in particular oral dosage forms.
    Type: Application
    Filed: June 1, 2001
    Publication date: November 1, 2001
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Jacky Vonderscher
  • Patent number: 6262022
    Abstract: Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesterified corn oil is provided representing a mixed mono-, di- and tri-glyceride suitable for the novel formulation. Dosage forms include in particular oral dosage forms.
    Type: Grant
    Filed: January 19, 2000
    Date of Patent: July 17, 2001
    Assignee: Novartis AG
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Jacky Vonderscher
  • Patent number: 6258808
    Abstract: Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-,di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesterified corn oil is provided representing a mixed mono-, di- and tri-glyceride suitable for the novel formulation. Dosage forms include in particular oral dosage forms.
    Type: Grant
    Filed: October 17, 2000
    Date of Patent: July 10, 2001
    Assignee: Novartis AG
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Jacky Vonderscher
  • Patent number: 6024978
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 -alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: November 2, 1998
    Date of Patent: February 15, 2000
    Assignee: Novartis AG
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter
  • Patent number: 6007840
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: November 2, 1998
    Date of Patent: December 28, 1999
    Assignee: Novartis AG
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter
  • Patent number: 5962017
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or ?Nva!.sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: February 17, 1998
    Date of Patent: October 5, 1999
    Assignee: Novartis G
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter
  • Patent number: 5962014
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or ?Nva!.sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: March 6, 1997
    Date of Patent: October 5, 1999
    Assignee: Novartis AG
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter
  • Patent number: 5916589
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or ?Nva!.sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: March 6, 1997
    Date of Patent: June 29, 1999
    Assignee: Novartis AG
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter
  • Patent number: 5866159
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or ?Nva!.sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: March 6, 1997
    Date of Patent: February 2, 1999
    Assignee: Novartis AG
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter
  • Patent number: 5756450
    Abstract: A combination of a pharmacologically active compound and a water soluble monoester of a saturated or unsaturated (C.sub.6-18) fatty acid and a polyol, especially a saccharide, particularly as a solid solution of the active compound in the monoester.The solid solution is especially suitable for substantially water insoluble active compounds, particularly such polypeptides, e.g. ciclosporins and is in all desirable weight ratios miscible with water.The invention also, in particular, provides pharmaceutical compositions comprising a cyclosporin as active ingredient together with a fatty acid saccharide monoester.
    Type: Grant
    Filed: November 7, 1994
    Date of Patent: May 26, 1998
    Assignee: Novartis Corporation
    Inventors: Lorenz Hahn, Birgit Hauer, Ulrich Posanski
  • Patent number: 5741512
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or ?Nva!.sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: April 27, 1995
    Date of Patent: April 21, 1998
    Assignee: Novartis Corporation
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter
  • Patent number: 5342625
    Abstract: Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
    Type: Grant
    Filed: December 15, 1992
    Date of Patent: August 30, 1994
    Assignee: Sandoz Ltd.
    Inventors: Birgit Hauer, Armin Meinzer, Ulrich Posanski, Friedrich Richter